Search

everythinglearnresearchcommunity

for

Search:↓

Generative AI tools can accurately score alopecia areata, reducing subjectivity in evaluations.

Generative AI tools like GPT-4o can effectively automate SALT scoring for alopecia areata, matching clinician accuracy.

AI improves vascular surgery by enhancing precision and safety, but doctors make final decisions.

Temporal triangular alopecia is a harmless, non-progressive hair loss condition.

BTA safely and effectively treats hair loss, and works better with FNS.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

AI can improve hair disorder diagnosis and treatment but can't replace doctors yet.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Bempikibart may help regrow hair in people with alopecia areata.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

AI improves aesthetic medicine but faces challenges like biases and privacy issues that need addressing for successful integration.

AI in robotic surgery improves precision and safety but faces cost and ethical challenges.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.